THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Ruling could spur tougher drug warnings

Mass. firms' plans unclear

By Todd Wallack
Globe Staff / March 6, 2009

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

Bay State pharmaceutical companies could decide to strengthen safety warnings on their products after Wednesday's Supreme Court ruling made it easier for patients to sue drug makers for injuries. But overall, the ruling drew surprisingly little reaction from biotechnology companies and industry groups. (Full article: 468 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass